CompaniesCorvas International

Corvas International

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (35)
View all

Total Trials

35

As Lead Sponsor

17

As Collaborator

18

Total Enrollment

35,762

By Phase

NA: 20PHASE2/PHASE3: 6PHASE4: 3PHASE3: 1

By Status

COMPLETED: 28UNKNOWN: 4ACTIVE_NOT_RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline35 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Funding History (14)
8-K
Apr 22, 2003
8-K
Mar 4, 2003
8-K
Feb 25, 2003
8-K
Jul 25, 2002
DEF 14A
Apr 26, 2002
DEF 14A
Apr 26, 2001
8-K
Oct 25, 2000
DEF 14A
Apr 20, 2000
DEF 14A
Apr 15, 1999
DEF 14A
Apr 16, 1998
Related Companies
Dendreon Pharmaceuticals
acquired